Relay Therapeutics Inc is trading at $14.33 (+6%) in pre-market, rebounding from sharp losses late last week after a rate-driven selloff in high-growth names.
- The move appears to be a technical bounce following Friday’s selloff in rate-sensitive biotech stocks.
- There are no fresh company-specific headlines, earnings, or FDA updates to drive the price action this morning.
- Broader market sentiment is contributing to the gains, with major U.S. equity indices also pointing higher in pre-market trading.